Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator …

…, MP Horn, D Aeberli, J Amsler, B Möller… - The Lancet …, 2021 - thelancet.com
Background B-cell-depleting therapies increase the risk of morbidity and mortality due to
COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting …

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to …

…, A Ciurea, L Brulhart, D Kyburz, B Möller… - Arthritis & …, 2007 - Wiley Online Library
Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor
necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as …

The− 308 tumour necrosis factor-α gene polymorphism predicts therapeutic response to TNFα-blockers in rheumatoid arthritis and spondyloarthritis patients

M Seitz, U Wirthmüller, B Möller, PM Villiger - Rheumatology, 2007 - academic.oup.com
Objective. To examine whether the G-to-A polymorphism at position −308 in the promoter of
the tumour necrosis factor-α (TNFα) gene influences the therapeutic response to TNFα-…

Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases

B Möller, PM Villiger - Springer seminars in immunopathology, 2006 - Springer
Blockade of cytokines, particularly of tumour necrosis factor alpha (TNF-α), in immuno-inflammatory
diseases, has led to the greatest advances in medicine of recent years. We did a …

Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.

…, U Kessler, R Gottschalk, G Stucki, B Möller - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To investigate whether treatment of anemia of chronic disease (ACD) in
patients with rheumatoid arthritis (RA) with recombinant human erythropoietin (rHu-Epo) in …

Citrullination in the periodontium—a possible link between periodontitis and rheumatoid arthritis

…, A Sculean, PJ Venables, J Potempa, B Möller… - Clinical oral …, 2016 - Springer
Objectives The aim of the present study was to assess human and bacterial peptidylarginine
deiminase (PAD) activity in the gingival crevicular fluid (GCF) in the context of serum levels …

Measuring finger joint cartilage by ultrasound as a promising alternative to conventional radiograph imaging

B Möller, H Bonel, M Rotzetter… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To evaluate the reliability and validity of a novel ultrasound (US) imaging method
to measure metacarpophalangeal (MCP) and proximal interphalangeal (PIP) finger joint …

Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis

…, SY Zimmermann, U Koehl, B Möller… - Annals of the …, 2007 - ard.bmj.com
Objectives: Regulatory T cells (Tregs) exert their anti-inflammatory activity predominantly by
cell contact-dependent mechanisms. A study was undertaken to investigate the regulatory …

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

…, K Bürki, I von Loga, R Micheroli, B Möller… - Annals of the …, 2021 - ard.bmj.com
Objectives To investigate whether the transient reduction in rheumatology services imposed
by virus containment measures during the COVID-19 pandemic was associated with …

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study

B Möller, M Pruijm, S Adler, A Scherer… - Annals of the …, 2015 - ard.bmj.com
Objectives Non-steroidal anti-inflammatory drugs (NSAIDs) may cause kidney damage. This
study assessed the impact of prolonged NSAID exposure on renal function in a large …